|
|
||||||||
MUCOSAL BIOLOGY
Inflammation Research Network, Departments of 1Physiology and Biophysics and 2Pharmacology and Therapeutics, University of Calgary, Calgary, Alberta, Canada
Submitted 5 July 2007 ; accepted in final form 15 November 2007
We examined the stimulus-secretion pathways whereby proteinase-activated receptor 2 (PAR-2) stimulates Cl– secretion in intestinal epithelial cells. SCBN and T84 epithelial monolayers grown on Snapwell supports and mounted in modified Ussing chambers were activated by the PAR-2-activating peptides SLIGRL-NH2 and 2-furoyl-LIGRLO-NH2. Short-circuit current (Isc) was used as a measure of net electrogenic ion transport. Basolateral, but not apical, application of SLIGRL-NH2 or 2-furoyl-LIGRLO-NH2 caused a concentration-dependent change in Isc that was significantly reduced in Cl–-free buffer and by the intracellular Ca2+ blockers thapsigargin and BAPTA-AM, but not by the Ca2+ channel blocker verapamil. Inhibitors of PKA (H-89) and CFTR (glibenclamide) also significantly reduced PAR-2-stimulated Cl– transport. PAR-2 activation was associated with increases in cAMP and intracellular Ca2+. Immunoblot analysis revealed increases in phosphorylation of epidermal growth factor (EGF) receptor (EGFR) tyrosine kinase, Src, Pyk2, cRaf, and ERK1/2 in response to PAR-2 activation. Pretreatment with inhibitors of cyclooxygenases (indomethacin), tyrosine kinases (genistein), EGFR (PD-153035), MEK (PD-98059 or U-0126), and Src (PP1) inhibited SLIGRL-NH2-induced increases in Isc. Inhibition of Src, but not matrix metalloproteinases, reduced EGFR phosphorylation. Reduced EGFR phosphorylation paralleled the reduction in PAR-2-stimulated Isc. We conclude that activation of basolateral, but not apical, PAR-2 induces epithelial Cl– secretion via cAMP- and Ca2+-dependent mechanisms. The secretory effect involves EGFR transactivation by Src, leading to subsequent ERK1/2 activation and increased cyclooxygenase activity.
ion transport; proteinases; signal transduction; protein kinase; cyclooxygenase; mitogen-activated protein kinase; extracellular signal-regulated kinase 1/2
This article has been cited by other articles:
![]() |
R. Ramachandran, K. Mihara, M. Mathur, M. D. Rochdi, M. Bouvier, K. DeFea, and M. D. Hollenberg Agonist-Biased Signaling via Proteinase Activated Receptor-2: Differential Activation of Calcium and Mitogen-Activated Protein Kinase Pathways Mol. Pharmacol., October 1, 2009; 76(4): 791 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Tripathi, K. M. Lammers, S. Goldblum, T. Shea-Donohue, S. Netzel-Arnett, M. S. Buzza, T. M. Antalis, S. N. Vogel, A. Zhao, S. Yang, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2 PNAS, September 29, 2009; 106(39): 16799 - 16804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. van der Merwe, F. Moreau, and W. K. MacNaughton Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms Am J Physiol Gastrointest Liver Physiol, June 1, 2009; 296(6): G1258 - G1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Q. van der Merwe, C. L. Ohland, C. L. Hirota, and W. K. MacNaughton Prostaglandin E2 Derived from Cyclooxygenases 1 and 2 Mediates Intestinal Epithelial Ion Transport Stimulated by the Activation of Protease-Activated Receptor 2 J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 747 - 752. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |